Regenerative Medicine Approach
Our clinical practice offers an integral functional regenerative medicine therapy for Long COVID (Post-Acute Sequelae of SARS-CoV-2), utilizing umbilical cord mesenchymal stem cells as the core therapeutic component. This approach is systematically supported by targeted physical therapy and evidence-based nutritional medicine to address the complex pathophysiology of post-viral syndrome and immune dysregulation.
Download our free comprehensive guide to the Nexus Stem Cells patient journey. Learn about logistics and travel planning, payment options, treatment timelines, post-therapy follow-up, and how our supportive rehabilitation and nutrition services integrate into your care—from your first inquiry through to discharge and recovery.
Download Guide (PDF)Our therapeutic strategy for Long COVID combines cellular regenerative approaches with functional rehabilitation and metabolic optimization to address the multifactorial nature of post-viral syndrome.
The foundation of our approach involves the precise intravenous and, when clinically indicated, targeted administration of umbilical cord-derived mesenchymal stem cells (UC-MSCs). Preclinical and early clinical studies describe immunomodulatory properties of these cells and their observed effects on inflammatory responses associated with Long COVID. Administration is performed under strict clinical guidelines to ensure patient safety and accurate delivery using minimally invasive techniques.
Following cellular administration, patients engage in a structured rehabilitation program specifically designed for post-viral conditions. This program integrates progressive physical therapy that balances energy conservation with gradual restoration of functional capacity, autonomic regulation, and cognitive endurance. The rehabilitation component is individually calibrated based on the extent of symptom manifestation, organ system involvement, and the patient's functional baseline.
Clinical visualization: Immune modulation and tissue targeting in Long COVID
Umbilical cord mesenchymal stem cells are utilized based on laboratory evidence describing their modulation of inflammatory cascades associated with post-viral immune dysregulation. Preclinical studies report effects on endothelial and tissue repair across multiple organ systems. Cellular processing follows established laboratory standards with documented quality control measures.
Learn MoreA graduated post-viral rehabilitation program is implemented to optimize functional outcomes while managing fatigue and post-exertional malaise. This includes autonomic training, pacing strategies, proprioceptive re-education, and gradual reintroduction of activity, all timed to coincide with expected phases of cellular integration and immune modulation.
Learn MoreEvidence-based nutritional guidance is provided to support cellular metabolism, mitochondrial function, and reduction of oxidative stress. These recommendations address nutritional factors that affect inflammatory responses, and the metabolic environment for recovery from post-viral illness.
Learn MoreLong COVID represents a complex clinical condition involving multiple physiological systems, including immune, neurological, and cardiovascular. The integration of cellular therapy with structured rehabilitation acknowledges the persistent inflammatory and autoimmune components that drive ongoing symptoms. The therapeutic objective extends beyond cellular administration to creating an optimal environment for functional integration and subsequent tissue repair and immune regulation.
"In clinical management of Long COVID, consideration must be given to both the biological aspects of immune dysregulation and the functional deficits experienced by patients. The regenerative medicine approach we employ seeks to address these dual considerations through a coordinated therapeutic strategy. This integrated methodology represents a logical progression in the comprehensive management of post-viral sequelae."
Medical illustration: Neuroinflammation and autonomic dysfunction in Long COVID
Histological visualization: Inflammatory markers and cellular distribution in post-viral states
Long COVID involves complex changes in immune function, inflammatory signaling, and tissue integrity. The persistence of viral components, autoimmunity, and mitochondrial dysfunction are key areas of investigation. Degenerative and inflammatory processes disrupt normal homeostatic balance, leading to multisystem symptoms including fatigue, cognitive impairment, and dysautonomia.
The regenerative approach we employ considers these pathophysiological aspects by addressing multiple components of the post-viral cascade. Cellular therapy aims to modulate local and systemic inflammatory environments while supporting tissue repair. Concurrent rehabilitation strategies address the functional aspects of recovery, and nutritional support targets metabolic factors that influence post-viral health.
Our evaluation process includes comprehensive assessment of Long COVID symptom burden, functional limitations, and individual patient factors to determine appropriateness for regenerative medicine intervention. This process involves detailed review of clinical history, review of diagnostic imaging and lab reports, and functional assessment.
Initiate Clinical EvaluationMedically reviewed by Dr. Guillermo Quezada, MD – Licensed Physician (Mexico) | Last updated: May 2026